As we have previously observed, innovation in health care, particularly on the product side, is heavily dependent on venture funding, and on the cycle of successful exits that generates capital for new investments. 2014 was an excellent year for venture finance, according to recently released stats from the National Venture Capital Association. (NVCA Reports) In the fourth quarter, venture funds raised $5.6 billion and for all of 2014, $29.8 billion was raised, up 69% from 2013. There were 96 new funds and 158 follow-on ones. On the exit side, there were 27 venture-backed IPOs during the fourth quarter that raised $4.4 billion and for the full year there were 115 such offerings which garnered $15.3 billion. The number of IPOs was up from 81 in 2013 and the amount raised rose from $ 11.1 billion. 16 of these IPOs in the fourth quarter were in health care, raising $1.7 billion. There were also 95 venture-backed M & A exits, of which 29 reported an aggregate deal value of $26.4 billion, although this is sharply skewed by Facebook’s absurd $19.5 billion purchase of Whatsapp. The full year saw 455 acquisitions of venture-backed firms, with 132 reporting a total value of $46 billion. The comparable 2013 numbers were 393 deals with 95 reporting transaction values of $16.9 billion. Health care in the fourth quarter accounted for 10 of these deals, with 7 of them reporting a total value of $2.7 billion. Of reported deals in the fourth quarter, 5 of 29 returned less than was invested, 6 were at 1-4X, 11 were at 4-10X and 7 were over ten times investment. The financing and exit markets appear to be in good health heading into 2015.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
What do you get when you combine a company with a commodity business model, that out of desperation massively overpays for another company that has a commodity business model? $10...
July 27, 2022
The “stupid” model for health care venture capital investing is alive and well. Everside health, which operates primary care clinics and has grown by acquiring other failing health care businesses,...
July 26, 2022
Apparently not even a cute name can save you if you have a stupid business. I constantly bemoan the mis-application of capital and health care is Exhibit A. Olive, another...
July 26, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace